MOLECULIN BIOTECH INC
Institutional coverage
15 13F filers hold $MBRX.
13F holders
15
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
1 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 15 · Source: 13F-HR01
PineBridge Investments, L.P.
3.57% of portfolio
150,042 sh
02
Smh Capital Advisors Inc.
—
12,582 sh
03
Sb Investment Advisers (uk) Ltd.
—
4,421 sh
04
BNP Paribas Asset Management Holding S.A.
—
1,835 sh
05
Atlantic Edge Private Wealth Management, LLC
—
491 sh
06
Beaton Management Co. Inc.
—
281 sh
07
JB Capital LLC
—
114 sh
08
Northwoods Investments LLC
—
43 sh
09
Banyan Capital Management, Inc.
—
32 sh
10
TB Capital Gestao de Recursos Ltda.
—
3 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $MBRX in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $MBRX in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 10:23 UTC.